Intco Medical Technology Co., Ltd.'s (SZSE:300677) 4.0% Gain Last Week Benefited Both Retail Investors Who Own 47% as Well as Insiders
Intco Medical Technology Co., Ltd.'s (SZSE:300677) 4.0% Gain Last Week Benefited Both Retail Investors Who Own 47% as Well as Insiders
Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index. Key Insights
主要见解
- Intco Medical Technology's significant retail investors ownership suggests that the key decisions are influenced by shareholders from the larger public
- The top 15 shareholders own 50% of the company
- Insider ownership in Intco Medical Technology is 36%
- 英科医疗的大量零售投资者持股表明关键决策受到更广泛公众的股东的影响。
- 前15大股东拥有该公司50%的股份。
- 英科医疗的内部持股比例为36%。
Every investor in Intco Medical Technology Co., Ltd. (SZSE:300677) should be aware of the most powerful shareholder groups. The group holding the most number of shares in the company, around 47% to be precise, is retail investors. Put another way, the group faces the maximum upside potential (or downside risk).
英科医疗有多个股东群体，而持股数量最多的群体约占公司股份的47%，即零售投资者。换句话说，该群体面临着最大的上行潜力（或下行风险）。
Retail investors gained the most after market cap touched CN¥17b last week, while insiders who own 36% also benefitted.
上周市值达到17亿人民币后，零售投资者获利最多，内部股东也获益，他们持有了36%的股份。
Let's delve deeper into each type of owner of Intco Medical Technology, beginning with the chart below.
接下来，我们会深入探讨英科医疗的每种持股人类型，首先是下面的图表。
What Does The Institutional Ownership Tell Us About Intco Medical Technology?
机构持股能告诉我们什么关于英科医疗？英科医疗的股份登记簿上已有机构，他们持有公司相当比例的股份。这表明专业投资者对公司的信誉性持有肯定态度。但是我们不能仅凭这个事实，因为机构有时也会做出不良投资，就像所有人一样。当多个机构持有股票时，存在它们处于“拥挤交易”的风险。当这样的交易失败时，多个方将竞相快速出售股票。在一个没有成长历史的公司中，此类风险更高。下面你可以看到英科医疗的历史收入和营业收入，但请记住，这只是整个故事的一部分。
Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.
机构投资者通常将自己的回报与常见的指数回报进行比较。因此，他们通常会考虑购买包括在相关基准指数中的较大公司。
Intco Medical Technology already has institutions on the share registry. Indeed, they own a respectable stake in the company. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see Intco Medical Technology's historic earnings and revenue below, but keep in mind there's always more to the story.
英科医疗已有机构出现在股份登记簿上。他们持有相当比例的公司股份。这表明专业投资者对公司的信誉性持有肯定态度。但是我们不能仅凭这个事实，因为机构有时也会做出不良投资，就像所有人一样。当多个机构持有股票时，存在它们处于“拥挤交易”的风险。当这样的交易失败时，多个方将竞相快速出售股票。在一个没有成长历史的公司中，此类风险更高。下面你可以看到英科医疗的历史收入和营业收入，但请记住，这只是整个故事的一部分。
Intco Medical Technology is not owned by hedge funds. Fang Yi Liu is currently the largest shareholder, with 36% of shares outstanding. In comparison, the second and third largest shareholders hold about 2.3% and 2.1% of the stock.
英科医疗没有被对冲基金持有。刘芳义是目前最大的股东，拥有公司36%的股份。相比之下，第二大和第三大股东持有约2.3%和2.1%的股票。
A closer look at our ownership figures suggests that the top 15 shareholders have a combined ownership of 50% implying that no single shareholder has a majority.
仔细观察我们的股权拆分数据表明，前15大股东持有的股权总和为50%，这意味着没有任何单一股东拥有多数股份。
Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. There is some analyst coverage of the stock, but it could still become more well known, with time.
上海阿拉丁生物化学技术股份有限公司的内部人员拥有重要比例，内部人员在这家总价值27亿人民币的公司中持有12亿人民币的股份。这可能表明创始人仍然拥有很多股份。您可以单击此处查看他们是否进行了买卖。
Insider Ownership Of Intco Medical Technology
英科医疗的内部持股比例。我们最新的数据表明内部人持有亦不少，他们在自己的名下持有价值61亿人民币的股票。这是相当显著的。大多数人都会很高兴看到董事会与他们一起投资。你可以获取此免费图表，其中显示了内部人员最近的交易情况。
The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.
内部人员的定义在不同国家可能略有不同，但董事会成员总是计入内部人员。管理层最终向董事会回答。然而，经理往往会成为执行董事会成员，尤其是如果他们是创始人或CEO。
I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.
我通常认为内部人士持股是一件好事。但是，在某些情况下，它会使其他股东更难以对董事会的决定进行问责。
Our most recent data indicates that insiders own a reasonable proportion of Intco Medical Technology Co., Ltd.. It has a market capitalization of just CN¥17b, and insiders have CN¥6.1b worth of shares in their own names. That's quite significant. Most would be pleased to see the board is investing alongside them. You may wish to access this free chart showing recent trading by insiders.
我认为深入看待公司的实际股东情况是非常有趣的。但是要真正得出结论，我们还需要考虑其他信息。实际上，我们已经发现英科医疗的一个警告信号，你需要知道。
General Public Ownership
一般大众所有权
The general public-- including retail investors -- own 47% stake in the company, and hence can't easily be ignored. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.
普通公众，包括散户投资者，持有公司47%的股份，因此不能被轻易忽视。虽然占有大量股份，但如果决策不符合其他大股东的意愿，则这种所有权规模可能不足以改变公司政策。
Next Steps:
下一步：
I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Case in point: We've spotted 1 warning sign for Intco Medical Technology you should be aware of.
我认为深入看待公司的实际股东情况是非常有趣的。但是要真正得出结论，我们还需要考虑其他信息。实际上，我们已经发现英科医疗的一个警告信号，你需要知道。
If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts.
如果您想发现分析师对未来增长的预测，请不要错过这份有关分析师预测的免费报告。
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
注：本文中的数据是使用最后一个财务报表日期结束的为期12个月的数据计算的。这可能与全年年度报告数据不一致。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对本文有反馈？关于内容有所顾虑？直接和我们联系。或者，发送电子邮件至editorial-team (at) simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论，只使用公正的方法论，我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议，也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意，我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
对本文有反馈？关于内容有所顾虑？直接和我们联系。或者发送电子邮件至editorial-team@simplywallst.com。